GC Wellbeing said Monday it has signed a license-in agreement with Israeli biotech company Raziel Therapeutics to ...
GC Green Cross Wellbeing announced on June 16 that it has secured topline results showing that its high-dose intravenous (IV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results